The purpose of this PQI is to review clinical information regarding fruquintinib (Fruzaqla®) treatment of metastatic colorectal cancer and to provide insights into best practices and treatment optimization.
2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST